The article states the startup obtained EUR 160000 (CHF 150000) from Venture Kick. NanoZymeX is a spinout from the University of Basel.
About NanoZymeX
Biotech startup developing a lipid nanoparticle-based platform for enzyme replacement therapy to improve delivery of therapeutic enzymes into target cells and lysosomes for rare genetic diseases such as lysosomal storage disorders and Pompe disease.
Basel, Switzerland
Read Company ProfileFrequently Asked Questions
What type of funding round did NanoZymeX raise?
NanoZymeX raised a grant round.
How much did NanoZymeX raise in its grant?
NanoZymeX raised $160,000 EUR in its grant.
Who invested in NanoZymeX's grant?
The investors in NanoZymeX's grant are: Venture Kick.
What type of investment was NanoZymeX's grant?
NanoZymeX's grant was a equity investment.
How will NanoZymeX use the funds from its grant?
NanoZymeX plans to use the funds for: develop lipid nanoparticle technology, conduct additional preclinical studies, prepare for scalable manufacturing, support future fundraising, transition toward clinical trials, company building, business development, prepare next stages of financing.